These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 7541613)
1. Intratumor microvessel density as a prognostic factor in cancer. Weidner N Am J Pathol; 1995 Jul; 147(1):9-19. PubMed ID: 7541613 [No Abstract] [Full Text] [Related]
3. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702 [TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
6. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710 [TBL] [Abstract][Full Text] [Related]
8. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489 [TBL] [Abstract][Full Text] [Related]
10. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472 [TBL] [Abstract][Full Text] [Related]
12. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200 [TBL] [Abstract][Full Text] [Related]
13. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178 [TBL] [Abstract][Full Text] [Related]
14. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829 [TBL] [Abstract][Full Text] [Related]
15. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Feng D; Nagy JA; Dvorak AM; Dvorak HF Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568 [TBL] [Abstract][Full Text] [Related]
16. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer. Chan JK; Loizzi V; Magistris A; Lin F; Rutgers J; Osann K; Disaia PJ; Berman ML Clin Cancer Res; 2004 Dec; 10(24):8538-43. PubMed ID: 15623636 [TBL] [Abstract][Full Text] [Related]